文献速递产科母胎医学

孕11-13周通过母体因素和生物标志物筛查子痫前期

Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-07-11

本研究基于三项前瞻性非干预筛查研究共61174例单胎妊娠,其中1770例(2.9%)发生子痫前期,在孕11+0至13+6周使用贝叶斯定理结合母体因素及MAP、UtA-PI、PlGF、PAPP-A等标志物筛查。在10%筛查阳性率下,联合母体因素、UtA-PI、MAP和PlGF可预测90%的早发型子痫前期、75%的早产型子痫前期和41%的足月型子痫前期,加入PAPP-A未改善筛查效果。筛查效果因种族起源而异。

要点

  • 联合母体因素、UtA-PI、MAP和PlGF在10%筛查阳性率下可预测90%早发型子痫前期。
  • 加入PAPP-A未改善筛查效果。
  • 筛查效果因种族起源而异,非裔加勒比裔女性的筛查阳性率更高(34%)。

核心结论

  • 在孕11-13周通过母体因素和生物标志物筛查可识别高比例的早发型和早产型子痫前期妊娠。

研究设计与样本

  • 数据来源于三项先前报道的前瞻性非干预筛查研究,共纳入61174例单胎妊娠,其中1770例(2.9%)发生子痫前期,采用贝叶斯定理结合母体因素和生物标志物 multiples of the median(MoM)值计算个体化风险。

主要发现

  • 发生子痫前期的妊娠与未发生者相比,UtA-PI和MAP的MoM值升高,PAPP-A和PlGF的MoM值降低,且四种标志物偏离正常值的程度在早发型子痫前期中大于晚发型。
  • 在10%筛查阳性率下,联合母体因素、UtA-PI、MAP和PlGF可预测90%的早发型子痫前期、75%的早产型子痫前期和41%的足月型子痫前期;加入PAPP-A未改善筛查效果。
  • 筛查效果取决于女性的种族起源;在高加索裔女性中,采用母体因素、MAP、UtA-PI和PlGF联合筛查并以<37周子痫前期风险1/100为切点,筛查阳性率为10%,早发型、早产型和足月型子痫前期的检出率分别为88%、69%和40%。
  • 在相同筛查方法和风险切点下,非裔加勒比裔女性的筛查阳性率为34%,早发型、早产型和足月型子痫前期的检出率分别为100%、92%和75%。

关键数值与推荐

  • 联合母体因素、UtA-PI、MAP和PlGF在10%筛查阳性率下预测早发型子痫前期的检出率为90%,早产型为75%,足月型为41%。
  • 在高加索裔女性中,采用风险切点1/100,筛查阳性率10%,早发型、早产型和足月型子痫前期检出率分别为88%、69%和40%。
  • 在非裔加勒比裔女性中,采用相同方法和风险切点,筛查阳性率34%,早发型、早产型和足月型子痫前期检出率分别为100%、92%和75%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the performance of screening for early, preterm and term pre-eclampsia (PE) at 11-13 weeks' gestation by maternal factors and combinations of mean arterial pressure (MAP), uterine artery (UtA) pulsatility index (PI), serum placental growth factor (PlGF) and serum pregnancy-associated plasma protein-A (PAPP-A). METHODS: The data for this study were derived from three previously reported prospective non-intervention screening studies at 11 + 0 to 13 + 6 weeks' gestation in a combined total of 61 174 singleton pregnancies, including 1770 (2.9%) that developed PE. Bayes' theorem was used to combine the prior distribution of gestational age at delivery with PE, obtained from maternal characteristics, with various combinations of biomarker multiples of the median (MoM) values to derive patient-specific risks of delivery with PE at < 37 weeks' gestation. The performance of such screening was estimated. RESULTS: In pregnancies that developed PE, compared to those without PE, the MoM values of UtA-PI and MAP were increased and those of PAPP-A and PlGF were decreased, and the deviation from normal was greater for early than late PE for all four biomarkers. Combined screening by maternal factors, UtA-PI, MAP and PlGF predicted 90% of early PE, 75% of preterm PE and 41% of term PE, at a screen-positive rate of 10%; inclusion of PAPP-A did not improve the performance of screening. The performance of screening depended on the racial origin of the women; on screening by a combination of maternal factors, MAP, UtA-PI and PlGF and using a risk cut-off of 1 in 100 for PE at < 37 weeks in Caucasian women, the screen-positive rate was 10% and detection rates for early, preterm and term PE were 88%, 69% and 40%, respectively. With the same method of screening and risk cut-off in women of Afro-Caribbean racial origin, the screen-positive rate was 34% and detection rates for early, preterm and term PE were 100%, 92% and 75%, respectively. CONCLUSION: Screening by maternal factors and biomarkers at 11-13 weeks' gestation can identify a high proportion of pregnancies that develop early and preterm PE. © 2018 Crown copyright. Ultrasound in Obstetrics & Gynecology © 2018 ISUOG.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tan MY, Syngelaki A, Poon LC, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2018. PMID: 29896812. doi:10.1002/uog.19112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。